We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
-1.05%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$750M
AUM Growth
+$15.2M
Cap. Flow
+$28.5M
Cap. Flow %
3.81%
Top 10 Hldgs %
32.25%
Holding
203
New
12
Increased
82
Reduced
87
Closed
19

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$19.1M
2
AMZN icon
Amazon
AMZN
+$5.56M
3
V icon
Visa
V
+$4.69M
4
DIS icon
Walt Disney
DIS
+$4.56M
5
VFC icon
VF Corp
VFC
+$3.31M

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 12.08%
3 Financials 10.9%
4 Consumer Staples 9.98%
5 Communication Services 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPEL icon
76
XPEL
XPEL
$1.22B
$649K 0.09%
8,558
-38
-0.4% -$3.13K
NET icon
77
Cloudflare
NET
$99B
$640K 0.09%
5,681
-15
-0.3% -$1.79K
DXCM icon
78
DexCom
DXCM
$32.2B
$626K 0.08%
4,580
+44
+1% +$5.55K
VIS icon
79
Vanguard Industrials ETF
VIS
$8.1B
$624K 0.08%
3,323
-212
-6% -$41.6K
SNAP icon
80
Snap
SNAP
$7.89B
$620K 0.08%
8,387
+361
+4% +$26.1K
RGEN icon
81
Repligen
RGEN
$7.96B
$605K 0.08%
2,094
-9
-0.4% -$2.31K
VDC icon
82
Vanguard Consumer Staples ETF
VDC
$7.97B
$603K 0.08%
3,363
-230
-6% -$42.6K
ZS icon
83
Zscaler
ZS
$24.5B
$590K 0.08%
2,251
+80
+4% +$20.1K
MRNA icon
84
Moderna
MRNA
$21.8B
$587K 0.08%
1,526
-57
-4% -$21K
ALNY icon
85
Alnylam Pharmaceuticals
ALNY
$27.5B
$551K 0.07%
2,917
+88
+3% +$16.5K
CMDY icon
86
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$557M
$549K 0.07%
+9,397
New +$524K
TNDM icon
87
Tandem Diabetes Care
TNDM
$1.34B
$547K 0.07%
4,586
-16
-0.3% -$1.76K
VFH icon
88
Vanguard Financials ETF
VFH
$13.5B
$537K 0.07%
5,799
-320
-5% -$29.5K
NOW icon
89
ServiceNow
NOW
$115B
$536K 0.07%
4,305
+90
+2% +$10.9K
EVBG
90
DELISTED
Everbridge, Inc. Common Stock
EVBG
$527K 0.07%
3,487
+246
+8% +$36.4K
ACMR icon
91
ACM Research
ACMR
$5.42B
$526K 0.07%
14,337
-54
-0.4% -$1.65K
AVLR
92
DELISTED
Avalara, Inc.
AVLR
$526K 0.07%
3,009
+148
+5% +$25.4K
FLGT icon
93
Fulgent Genetics
FLGT
$470M
$523K 0.07%
5,815
-18
-0.3% -$1.64K
CRWD icon
94
CrowdStrike
CRWD
$194B
$507K 0.07%
8,252
-24
-0.3% -$1.55K
VOX icon
95
Vanguard Communication Services ETF
VOX
$5.59B
$504K 0.07%
3,583
-325
-8% -$47.2K
BND icon
96
Vanguard Total Bond Market
BND
$157B
$492K 0.07%
5,752
-37
-0.6% -$3.19K
GM icon
97
General Motors
GM
$80.4B
$492K 0.07%
9,338
+74
+0.8% +$3.93K
XYZ
98
Block Inc
XYZ
$48.4B
$489K 0.07%
2,038
+99
+5% +$25.4K
BPMC
99
DELISTED
Blueprint Medicines
BPMC
$488K 0.07%
4,746
+242
+5% +$22.5K
INSP icon
100
Inspire Medical Systems
INSP
$1.45B
$480K 0.06%
2,060
-10
-0.5% -$2.09K

Similar funds

Spearhead Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Spearhead Capital Advisors held 203 positions worth $750M, up 2.1% from $735M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Spearhead Capital Advisors deployed $28.5M of net new capital in Q3 2021, opening 12 new positions and adding to 82 existing holdings. Its largest new stake was Realty Income: 283,375 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Costco, an estimated $1.5M trimmed.

  • Spearhead Capital Advisors's largest Q3 2021 buy was Realty Income: 283,375 shares worth $17.8M.
  • Spearhead Capital Advisors added most to Amazon in Q3 2021, an estimated $5.56M increase.
  • Spearhead Capital Advisors's biggest Q3 2021 reduction was Costco, cutting an estimated $1.5M.
  • Spearhead Capital Advisors fully exited Emerson Electric in Q3 2021, selling an estimated $9.31M.
  • Spearhead Capital Advisors's ten largest holdings make up 32% of its $750M portfolio in Q3 2021.
  • Spearhead Capital Advisors opened 12 new positions and closed 19 in Q3 2021.
  • Spearhead Capital Advisors's portfolio value rose 2.1% quarter-over-quarter to $750M.

Based on Spearhead Capital Advisors's 13F filing for Q3 2021, filed 27 Oct 2021.